News

AstraZeneca announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer.…
Read More...

Covectra, a leader in track and trace solutions, announced the next generation of StellaGuard, a smart label and mobile authentication solution that will enable brand managers and…
Read More...

Junshi Biosciences a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced that the National…
Read More...

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate the safety, tolerability, and immunogenicity of the…
Read More...

Eli Lilly and Company and Rigel Pharmaceuticals, Inc. announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a…
Read More...

Provention Bio, Inc. a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a…
Read More...

Altimmune, Inc. a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND)…
Read More...

Boston Immune Technologies and Therapeutics, Inc. (BITT), a privately held developer of novel antagonist antibodies for cancer and other diseases, and BeiGene, Ltd. announced that they…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new…
Read More...

Iterion Therapeutics, Inc. ("Iterion"), a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, announced that it has raised $17 million USD in a…
Read More...

Johnson & Johnson announced that Janssen-Cilag International N.V., has submitted a conditional Marketing Authorisation Application (cMAA) to the European Medicines Agency (EMA)…
Read More...

Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that animal testing has commenced with two…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto (sacubitril/valsartan): to reduce the risk of…
Read More...

AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions,  announced a new collaboration with AstraZeneca, a global science-led…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies…
Read More...

Avexegen Therapeutics Inc. announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's Small Business Innovation Research Program (SBIR)…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, announced an…
Read More...

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of…
Read More...

The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults…
Read More...

MindMed a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with…
Read More...